21.40
price down icon0.70%   -0.15
pre-market  Pre-mercato:  22.48   1.08   +5.05%
loading

Caredx Inc Borsa (CDNA) Ultime notizie

pulisher
May 11, 2026

CareDx (CDNA) Successfully Resolves Legal Action - GuruFocus

May 11, 2026
pulisher
May 11, 2026

How Investors Are Reacting To CareDx (CDNA) Profit Return, Higher 2026 Outlook And New Shelf Registration - simplywall.st

May 11, 2026
pulisher
May 11, 2026

CareDx(CDNA) Stock Options Chain | Quotes & News - Moomoo

May 11, 2026
pulisher
May 11, 2026

CareDx Announces Dismissal of 2021 Qui Tam Suit - The Joplin Globe

May 11, 2026
pulisher
May 10, 2026

Earnings Preview: CareDx to Report Financial Results Post-market on April 28 - Moomoo

May 10, 2026
pulisher
May 07, 2026

Technical Reactions to CDNA Trends in Macro Strategies - Stock Traders Daily

May 07, 2026
pulisher
May 06, 2026

Insider Sell: Jeffrey Novack Sells 2,688 Shares of CareDx Inc (C - GuruFocus

May 06, 2026
pulisher
May 06, 2026

CareDx (NASDAQ: CDNA) counsel's 2,688-share sale under 10b5-1 - Stock Titan

May 06, 2026
pulisher
May 05, 2026

CareDx (CDNA) Q1 2026 Earnings Call Transcript - AOL.com

May 05, 2026
pulisher
May 05, 2026

[144] CareDx, Inc. SEC Filing - Stock Titan

May 05, 2026
pulisher
May 05, 2026

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The National Law Review

May 05, 2026
pulisher
May 04, 2026

A Look At CareDx (CDNA) Valuation After Recent Share Price Momentum Cools - Yahoo Finance

May 04, 2026
pulisher
May 04, 2026

CareDx (CDNA) General Counsel has 2,873 shares withheld to cover RSU taxes - Stock Titan

May 04, 2026
pulisher
May 04, 2026

How Investors Are Reacting To CareDx (CDNA) Profitability Milestone And Higher 2026 Revenue Guidance - Sahm

May 04, 2026
pulisher
May 03, 2026

CareDx (NASDAQ:CDNA) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat

May 03, 2026
pulisher
May 02, 2026

MSN Money - MSN

May 02, 2026
pulisher
May 01, 2026

23 new CareDx hires receive 63,856 stock units under Nasdaq rule - Stock Titan

May 01, 2026
pulisher
May 01, 2026

CareDx sharpens focus on core testing services - MSN

May 01, 2026
pulisher
May 01, 2026

CareDx (CDNA) Q2 2025 Earnings Transcript - AOL.com

May 01, 2026
pulisher
Apr 30, 2026

CareDx : 2025 Annual Report - marketscreener.com

Apr 30, 2026
pulisher
Apr 30, 2026

CareDx : 2026 Proxy Statement - marketscreener.com

Apr 30, 2026
pulisher
Apr 30, 2026

CDNA SEC FilingsCaredx 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

Analysts Conflicted on These Healthcare Names: CareDx (CDNA), Biogen (BIIB) and Guardant Health (GH) - The Globe and Mail

Apr 30, 2026
pulisher
Apr 30, 2026

H.C. Wainwright reiterates Neutral rating on CareDx stock By Investing.com - Investing.com Australia

Apr 30, 2026
pulisher
Apr 30, 2026

H.C. Wainwright reiterates Neutral rating on CareDx stock - Investing.com

Apr 30, 2026
pulisher
Apr 30, 2026

Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX), Stryker (SYK) and CareDx (CDNA) - The Globe and Mail

Apr 30, 2026
pulisher
Apr 30, 2026

CareDx Acquires Navaris and Divests Lab Products to Accelerate Growth - HarianBasis.co

Apr 30, 2026
pulisher
Apr 30, 2026

Analysts Offer Insights on Healthcare Companies: CareDx (CDNA) and Ultragenyx Pharmaceutical (RARE) - The Globe and Mail

Apr 30, 2026
pulisher
Apr 29, 2026

CareDx Earnings Call: Growth Accelerates Amid Bold Pivot - TipRanks

Apr 29, 2026
pulisher
Apr 29, 2026

CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing - The National Law Review

Apr 29, 2026
pulisher
Apr 29, 2026

Q1 2026 Presentation (04/28/2026 00: 00 - marketscreener.com

Apr 29, 2026
pulisher
Apr 29, 2026

CareDx (NASDAQ:CDNA) Trading Down 8.7%What's Next? - MarketBeat

Apr 29, 2026
pulisher
Apr 29, 2026

CareDx sharpens precision medicine focus with $260m Naveris acquisition - Yahoo Finance

Apr 29, 2026
pulisher
Apr 29, 2026

Caredx to acquire Naveris for up to $260 million - BioWorld News

Apr 29, 2026
pulisher
Apr 29, 2026

CareDx : ESG Report (CareDx 2026 ESG Report) - marketscreener.com

Apr 29, 2026
pulisher
Apr 29, 2026

CDNA Maintained by BTIG -- Price Target Raised to $28.00 - GuruFocus

Apr 29, 2026
pulisher
Apr 29, 2026

CareDx to Acquire Oncology Diagnostics Company Naveris for $160 Million - Clinical Lab Products

Apr 29, 2026
pulisher
Apr 29, 2026

CareDx, Inc Q1 2026 Earnings Call Summary - Yahoo Finance

Apr 29, 2026
pulisher
Apr 29, 2026

CareDx (NASDAQ:CDNA) Price Target Raised to $28.00 at BTIG Research - MarketBeat

Apr 29, 2026
pulisher
Apr 29, 2026

CareDx, Inc (NASDAQ:CDNA) Q1 2026 Earnings Call Transcript - Insider Monkey

Apr 29, 2026
pulisher
Apr 29, 2026

BTIG raises CareDx stock price target on oncology diagnostics deal - Investing.com UK

Apr 29, 2026
pulisher
Apr 29, 2026

BTIG raises CareDx stock price target on oncology diagnostics deal By Investing.com - Investing.com Nigeria

Apr 29, 2026
pulisher
Apr 29, 2026

CareDx Inc (CDNA) Q1 2026 Earnings Call Highlights: Strong Reven - GuruFocus

Apr 29, 2026
pulisher
Apr 29, 2026

CareDx (CDNA) Returns To Quarterly Profit Challenging Skepticism Around Its Earnings Story - Sahm

Apr 29, 2026
pulisher
Apr 29, 2026

CareDx Announces First Quarter 2026 Financial Results - BioSpace

Apr 29, 2026
pulisher
Apr 29, 2026

CareDx Q1 2026 Earnings Call Transcript - MarketBeat

Apr 29, 2026
pulisher
Apr 28, 2026

CareDx to acquire Naveris for $160M up-front, $100M in revenue milestones - TipRanks

Apr 28, 2026
pulisher
Apr 28, 2026

CareDx to acquire oncology diagnostics firm Naveris for $160M By Investing.com - Investing.com South Africa

Apr 28, 2026
pulisher
Apr 28, 2026

CareDx (CDNA) Q1 2026: EPS $0.05 Beats -$0.03 Est; Revenue $118M - GuruFocus

Apr 28, 2026
pulisher
Apr 28, 2026

CareDx to Acquire Naveris to Expand Into Cancer MRD Testing - Yahoo Finance

Apr 28, 2026
pulisher
Apr 28, 2026

CDNA Adjusts 2026 EBITDA Forecast to $43M-$57M Range - GuruFocus

Apr 28, 2026
pulisher
Apr 28, 2026

CDNA Expands Precision Medicine Services with Naveris Acquisitio - GuruFocus

Apr 28, 2026
LH LH
$257.35
price up icon 0.89%
MTD MTD
$1,072.45
price down icon 0.56%
$145.70
price up icon 2.24%
IQV IQV
$175.06
price up icon 0.87%
$204.21
price up icon 2.55%
A A
$112.90
price up icon 1.29%
Capitalizzazione:     |  Volume (24 ore):